HDAC9 and cancer: Because deregulation of HDAC function has been found in cancer and other pathologies, inhibitors of HDACs have gained importance as potential therapeutics and as tools for chemical genomics investigations (Shames et al, 2006; Zhong et al, 2007; Marshall et al, 2009).